Nvidia's new RTX 5000 GPU lineup promises to enhance gaming performance in multiple games, but PC requirements for Ubisoft's new title suggest an upgrade isn't urgently needed.

Want more housing market stories from Lance LambertsResiClubin your inbox?Subscribeto theResiClubnewsletter.Among the 26 forecasts tracked by ResiClub in its final 2025 home price forecast roundup, the average prediction is a +2.7% increase in U.S. home prices this year.Keep in mind that the above figure is a forecast for nationally aggregated home prices. On a regional and local basis, home price swings can vary greatly from the national figure. For example, on a year-over-year basis, U.S. home prices as measured by the Zillow Home Value Index are up 2.6%, while home prices in the Rochester, New York metro area are up 8.2% and home prices in the Punta Gorda, Florida metro area are down 8.3% during that same timeframe.To better understand how regional home prices may vary in 2025, ResiClub reached out to economists at Zillowwhose forecast of U.S. home prices rising by +2.9% in calendar 2025 aligns with the average modeland economists at Moodyswhose forecast of U.S. home prices falling by -0.4% in 2025 is among the most bearishto gather their metro-level home price forecasts.Lets take a look at the metro-level forecasts.Click here to view an interactive of Zillows 2025 metro area home price forecast.Why does Zillow think most housing markets will see positive home price appreciation in 2025?Zillow economists write that: Opposing forces are working to keep home values climbing, but only at a modest pace. Inventory remains very low by historical standards, which, paired with expectations for declining mortgage rates and modest improvements in other leading indicators of home sales, is helping to buoy home value appreciation. At the same time, modest increases in new for-sale listings and persistently high mortgage rates are combining to limit price growth.Click here to view an interactive of Moodys 2025 metro area home price forecast.The forecast by Moodys chief economist Mark Zandi has U.S. home prices, as measured by the Moody's Analytics Repeat Sales House Price Index, falling 0.4% in 2025, followed by 0.7% uptick in 2026.Why is Moodys still slightly bearish when it comes to home prices?We expect homes for sale to steadily increase as more existing homeowners need to sell for demographic reasonsdeath, divorce, children, job changeand lower mortgage rates help ease their interest rate lock. The [potentially] lower rates will also support housing demand, but the increase in housing supply will be even more significant, weighing on house price gains, Zandi tells ResiClub.In total, there are 380 metro-area housing markets for which both Zillow and Moodys are forecasting 2025 home prices. (See the interactive chart above.) That includes:193 markets: Metros that both Zillow and Moodys forecast will see a home price increase156 markets: Metros that Zillow forecast will see a home price increase and Moodys forecast will see a home price decline22 markets: Metros that Zillow forecast will see a home price decrease and Moodys forecast will see a home price increase9 markets: Metros that both Zillow and Moodys forecast will see a home price declineWhat is ResiClubs take? Broadly speaking, housing markets where inventory (i.e., active listings) has returned to pre-pandemic levels have experienced weaker home price growth (or outright declines) over the past 30 months since the pandemic housing boom fizzled out. Conversely, housing markets where inventory remains far below pre-pandemic levels have, generally speaking, experienced stronger home price growth over the past 30 months.Using active inventory as a guide, we expect the greatest pricing resilience in 2025 to be in Midwest and Northeast markets, while the greatest pricing softness is likely in Gulf markets such as New Orleans, Austin, and Punta Gorda. Zillow appears to be overly optimistic about Southwest Florida, whereas we believe Moodys is too bearish on the West Coast.Regardless of how regional inventory (see our latest monthly inventory update) or regional home prices (see our latest monthly home price update) perform in 2025, well be closely tracking the trends to keep you informed of any shifts.

Several years ago, a little-known drug named Ozempicpreviously used only to treat diabetesemerged as a promising new drug for weight management.The Food and Drug Administrations approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, or GLP-1.Today, GLP-1 drugs, including Wegovy, Mounjaro, and Zepbound, have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug, and forecasts show that by 2030, 1 in 10 Americans will likely be using these medications.Now, research from my lab and others suggests that GLP-1 drugs could help treat dozens of other ailments as well, including cognitive issues and addiction problems. However, my colleagues and I also found previously unidentified risks.I am a physician-scientist and I direct a clinical epidemiology center focused on addressing public healths most urgent questions. My team works to address critical knowledge gaps about COVID-19, long COVID, influenza, vaccines, effectiveness and risks of commonly used drugs, and more.On January 20, 2025, my team published a study of more than 2.4 million people that evaluated the risks and benefits of GLP-1 drugs across 175 possible health outcomes. We found that these drugs lowered risks of 42 health outcomes, nearly a quarter of the total that we analyzed. These include neurocognitive disorders such as Alzheimers disease and dementia, substance use and addiction disorders, clotting disorders, and several other conditions.Unfortunately, we also found that GLP-1 drugs come with significant side effects and increase the risk of 19 health conditions we studied, such as gastrointestinal issues, kidney stones, and acute pancreatitis, in which the pancreas becomes inflamed and dysfunctional.Cognitive benefitsOne of the most important health benefits we found was that the GLP-1 drugs lowered the risk of neurodegenerative disorders, including Alzheimers disease and dementia. These findings align with other research, including evidence from preclinical studies showing that these drugs may reduce inflammation in the brain and enhance the brains ability to form and strengthen connections between its cells, improving how they communicate with one another. These effects contribute to mitigating cognitive decline.Two other key studies have shown that patients treated with a GLP-1 drug for diabetes had a lower risk of dementia.All of these studies strongly point to a potential therapeutic use of GLP-1 drugs in treatment of the cognitive decline. Ongoing randomized trialsthe gold standard for evaluating new uses of drugsare looking at the effects of GLP-1 drugs in early Alzheimers disease, with results expected later in 2025.Curbing addiction and suicidal ideationGLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids, and stimulants. This may be due to the ability of these drugs to modulate reward pathways, impulse control, and inflammatory processes in the brain.The effectiveness of GLP-1 drugs in curbing addictive behavior may explain their spectacular success in treating obesity, a chronic disease state that many have suggested is indeed a food addiction disorder.Our study demonstrated a reduced risk of suicidal thoughts and self-harm among people using GLP-1 drugs. This finding is particularly significant given earlier reports of suicidal thoughts and self-injury in people using GLP-1 drugs. In response to those reports, the European Medicines Agency conducted a review of all available data and concluded that there was no evidence of increased risk of suicidality in people using GLP-1 drugs.Now at least two studies, including our own, show that GLP-1 drugs actually reduce the risk of suicidality.Other benefitsIn addition to the well-documented effects of GLP-1 drugs in reducing risks of adverse cardiovascular and kidney outcomes, our study shows a significant effect in reducing risk of blood clotting as well as deep vein thrombosis and pulmonary embolism.One puzzling finding in our study is the reduced risk of infectious diseases such as pneumonia and sepsis. Our data complements another recent study that came to a similar conclusion showing that GLP-1 drugs reduced risk of cardiovascular death and death due to infectious causes, primarily COVID-19.This is especially important since COVID-19 is regarded as a significant cardiovascular risk factor. Whether GLP-1 drugs completely offset the increased risk of cardiovascular disease associated with COVID-19 needs to be thoroughly evaluated.GLP-1 drugs may also be useful in treating fatty liver disease and conditions ranging from asthma to chronic obstructive pulmonary disease, sleep apnea, osteoarthritis, depression, and eye disorders.Risks and challengesDespite their broad therapeutic potential, GLP-1 drugs are not without risks.Gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease are among the most common adverse effects associated with GLP-1 drugs.Our study also identified other risks, including low blood pressure, sleep problems, headaches, formation of kidney stones, and gall bladder disease and diseases associated with the bile ducts. We also saw increased risks of drug-induced inflammation of the kidneys and pancreasboth serious conditions that can result in long-term health problems. These findings underscore the importance of careful monitoring in people who are taking GLP-1 medications.A significant challenge with using GLP-1 drugs is the high rates at which patients stop using them, often driven by their exorbitant cost or the emergence of adverse effects. Discontinuation can lead to rapid weight gain.Thats a problem, because obesity is a chronic disease. GLP-1 drugs provide effective treatment but do not address the underlying causes of obesity and metabolic dysfunction. As a result, GLP-1 drugs need to be taken long term to sustain their effectiveness and prevent rebound weight gain.In addition, many questions remain about the long-term effectiveness and risks of these drugs as well as whether there are differences between GLP-1 formulations. Addressing these questions is critical to guide clinical practice.Ziyad Al-Aly is a clinical epidemiologist at Washington University in St. Louis.This article is republished from The Conversation under a Creative Commons license. Read the original article.

Dramatically veined marble, colourful storage displays and original architectural features come together in this Brooklyn loft renovated by locally based Batliboi Studio.The space in an early 20th-century former manufacturing building on Atlantic Avenue was converted into a two-bedroom, two-bathroom apartment for Valerie Tsvetkova, who manages the creative services department for beauty brand Elizabeth Arden.The renovation of this industrial space involved uncovering original ceiling beams and exposing ductworkBatliboi Studio founder Hormuz Batliboi helped his client realise the very specific vision she had for the space, exposing the original structure and introducing touches of drama."She wanted an organic yet eclectic feel while maintaining a warm material palette," Batliboi told Dezeen.Elements like a green shelving unit and matching pendant lights enliven the dining space"We approached this by embracing the industrial history of the building and uncovering historic elements like the wood beams and metal structural connections," he continuedStarting with a blank slate in terms of layout, all the utilities were centralised for optimum functionality.A stainless steel counter, backsplash and floating shelf in the kitchen nod to existing industrial elementsTo achieve this, the floor level for the kitchen and bathrooms was raised to run plumbing, gas and electrical underneath."This arrangement allowed us to improve the overall circulation and flow of the layout, and we incorporated remnant stone from the kitchen at the step up a solution that was not only visually appealing but also added to the loft's overall character," said Batliboi.Cabinetry from Reform was customised for the kitchen and hallway storageModular off-the-shelf cabinetry with a wood finish from Reform was customised for the kitchen, and paired with a stainless steel counter, backsplash and floating shelf that plays off the exposed ceiling ductwork.A large island is topped with dramatically veined stone that's repeated in the shower and atop the vanity in the main bathroom.A workspace makes the most of natural light from the loft's large windowsThis bathroom also features penny tiling, olive green walls and brass fixtures, while the second is lined with inky black zellige tiles on the walls and matte black tiles across the floor."These elements add a certain richness and mystique to the space, further accentuated by the natural light streaming from the massive window in the bathroom," Batliboi said.Read: Bureau Tempo applies subtle tones and textures to renovated Brooklyn loftThe loft's wooden ceiling beams originally hidden by a dropped ceiling and large windows are best appreciated in the open-plan living and dining area.Here, a large dining table sits in front of a bespoke storage element that's topped with a swooping green strip.The primary bathroom features dramatically veined marble, penny tiles and brass fixtures"This unique piece, fashioned as an organic green ribbon, anchors one wall and also functions as a sideboard," Batliboi said."The colour was carefully matched to the dining room pendants that the client already had her heart set on, ensuring a harmonious balance in the room."A second bathroom is lined with inky black zellige tilesBrooklyn's industrial past has left a plethora of similar warehouse buildings to be converted for residential use.Other examples with recently completed interiors include an apartment renovation inside a former chocolate factory and a loft that was "gently redesigned" using subtle tones and textures.The photography is by Ashok Sinha.The post Batliboi Studio combines industrial and playful elements in Brooklyn loft appeared first on Dezeen.

You might assume that tech-savvy people are the most open to using AI, but research suggests it's actually those who are least familiar with it.

Nikons latest midrange full-frame mirrorless camera offers pro-level features without the pro price.

The Times wanted to go online in 1996 with nytimes.com. But the domain was already owned by a Times reporter.

Apple's 2025 iPhone lineup could add a new dimension with the iPhone 17 Slim. Here's what the rumor mill believes is on the way.A render of what the iPhone 17 Slim could look likeThe iPhone 17 generation is expected this September, as usual for Apple's flagship device releases. However, the 2025 collection could make a big change to the lineup, with the replacement of one of the models.According to multiple rumors, the iPhone 17 Plus could be removed from the lineup, due to a lack of popularity compared to the other models. In its place, Apple could introduce something brand new. Continue Reading on AppleInsider | Discuss on our Forums

CarPlay has come a long way since its release, and four years after install, the Boss BE10ACP remains an affordable gateway to integrating Apple technologies into your car.The Boss BE10ACP CarPlay Receiver head unit and the display. If you need to replace your car stereo, there are options on the market that provide support for Apple's CarPlay system. The problem in many cases is that you could end up needing to use a single-DIN head unit, a compact size that doesn't necessarily offer space for a display.The Boss BE10ACP is a single-DIN head unit with a large display. Rather than being a double-DIN unit that would keep the display within the main unit's dimensions, the display is mounted so it sticks out a short distance from the front of the unit itself. Continue Reading on AppleInsider | Discuss on our Forums

Enhance your Blender projects with Easy Overlay! https://blendermarket.com/products/ea... This powerful addon lets you add stunning visual overlays like grids, scratches, film effects, and moreperfect for animations, presentations, or stylized renders. #Blender3D #b3d #references #ref #Visual #Effects #Stylized #Art #Blender #Addons(Feed generated with FetchRSS)